ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

643
Analysis
Health Care • South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
•28 Apr 2017 14:09

The Week That Was in NorthAsia@Smartkarma - THAAD Deployment, Mobile Lineage, and Activism in Japan

KoreaScott Laprise/ ä¹å¤©č™Ž and Prasenjit K. Basu have provided great insights regarding the political turmoil surrounding North Korea. Scott makes it...

Logo
405 Views
Share
•28 Apr 2017 05:42

EM Managers - Most Avoided Stocks

• The 830 stocks in the benchmark MSCI Emerging Market Index all represent legitimate investments for global EM active managers. Whilst publicly...

Logo
498 Views
Share
bearish•Celltrion Inc
•22 Apr 2017 02:17

The Disconnect Is Growing

Celltrion Inc (068270 KS) 's Inflectra, a biosimilar to Johnson & Johnson (JNJ US) 's Remicade, had little impact on the critical U.S. market...

Share
•09 Mar 2017 23:38

Alpha Generation from Share Buybacks in Korea (2017 YTD)

In this report, we have identifiedĀ 26 stocksĀ in the Korean stock market that have announced share buyback programs so farĀ in 2017. These stocks...

Logo
1.4k Views
Share
•08 Mar 2017 10:59

Update on the Put Back Option Clause for IPOs in the Korea Stock Market

This report is an update on the implementation of the "put-back option clause" for IPOs in the Korea Stock Market (for companies applying under the...

Logo
532 Views
Share
x